Japan approves Novavax COVID-19 vaccine


              FILE - Shigeyuki Goto, newly appointed minister of Health, Labour and Welfare, arrives at the prime minister's official residence Monday, Oct. 4, 2021, in Tokyo. Japan’s health ministry on Tuesday, April 19, 2022, formally approved Novavax's COVID-19 vaccine, a fourth foreign-developed tool to combat the infections as the country sees signs of a resurgence led by a subvariant of fast-spreading omicron. (AP Photo/Eugene Hoshiko, File)
            
              FILE - A vial of the Phase 3 Novavax coronavirus vaccine prepared for use in a trial at St. George's University hospital in London, Oct. 7, 2020. Japan’s health ministry on Tuesday, April 19, 2022, formally approved Novavax's COVID-19 vaccine, a fourth foreign-developed tool to combat the infections as the country sees signs of a resurgence led by a subvariant of fast-spreading omicron. (AP Photo/Alastair Grant, File)